B26 peptoid
B26 peptoid is a ptoid antibiotic. B26 peptoid exhibits excellent broad-spectrum activity and high selectivity toward a panel of Gram-positive and Gram-negative bacterial strains. B26 peptoid disrupts bacterial membranes and has bactericidal activity. B26 peptoid shows low propensity for bacterial drug resistance. B26 peptoid can be used for the research of bacterial infection.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Formel: C58H114N12O8
- Molecular Weight:1107.60
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Antibiotic Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
In Vitro
B26 peptoid (16 h) potently inhibits the growth of vancomycin-resistant E. faecalis, methicillin-resistant S. aureus, methicillin-resistant S. epidermidis, E. coli, P. aeruginosa, and K. pneumoniae with MIC values ranging from <3 μg/mL[1].
B26 peptoid (2× MIC; 2 h) disrupts the cell membranes of methicillin-resistant S. aureus and E. coli, allowing propidium iodide to enter and stain bacterial cells[1].
B26 peptoid (2× MIC; 2 h) causes severe membrane disruption and cellular damage in methicillin-resistant S. aureus and E. coli, as visualized by transmission electron microscopy[1].
B26 peptoid maintains stable, consistent antimicrobial activity against methicillin-resistant S. aureus over 14 serial passages, with no significant development of bacterial drug resistance[1].
B26 peptoid (12 μg/mL; 0-2 h) rapidly kills methicillin-resistant S. aureus and E. coli[1].
B26 peptoid (1 h) has low hemolytic toxicity toward human red blood cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:methicillin-resistant S. aureus; E. col
-
Concentration:12 μg/mL
-
Incubation Time:0-2 h
-
Result:Killed methicillin-resistant S. aureus within 2 hours and E. coli within 1 hour.
Chemical Information
-
Molecular Weight 1107.60
-
Formel C58H114N12O8
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Gram Staining of Tissue Sections
Gram staining of tissue sections is a histochemical technique used to differentiate Gram-positive and Gram-negative bacteria within histological specimens based on differences in bacterial cell wall structure and dye retention, adapted from classical bacteriological Gram staining into tissue-compatible “histological Gram stain” variants. In tissue applications, modifications of the Brown-Hopps and Brown-Brenn methods are commonly used to improve differentiation of microorganisms embedded within host connective tissue and to reduce overstaining or loss of Gram-negative signal, which are known limitations of earlier approaches. The principle relies on crystal violet-iodine complex retention in Gram-positive organisms and subsequent decolorization and counterstaining steps that allow contrast visualization of Gram-negative organisms against tissue background.
-
Bacterial live/dead nucleic-acid viability staining
The LIVE/DEAD bacterial viability staining method is based on differential permeability of nucleic-acid-binding fluorescent dyes, most commonly SYTO 9 and propidium iodide (PI), which enables discrimination of bacterial populations with intact versus compromised cytoplasmic membranes. SYTO 9 penetrates both intact and damaged bacterial membranes and binds nucleic acids to produce green fluorescence, whereas propidium iodide penetrates only cells with compromised membranes and fluoresces red while also reducing SYTO 9 signal through competitive binding and fluorescence interactions. The resulting fluorescence pattern is interpreted as a proxy for membrane integrity, which is widely used as an indicator of bacterial viability in microscopy, flow cytometry, and spectroscopic platforms. However, mechanistic studies show that SYTO 9 and PI interactions involve displacement and fluorescence resonance energy transfer effects, which can influence signal interpretation depending on dye ratios a
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)